Robert E. Hoffman

Insider Reports History

Entity
Individual
Location
Arena Pharmaceuticals Inc, 6166 Nancy Rider Drive, San Diego, CA
Signature
/s/ Mark Andersen, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Hoffman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FibroBiologics Inc. Director Common Stock 7.5K $14.4K $1.91 Jan 24, 2024 Direct
Kintara Therapeutics, Inc. President, CEO and Interim CFO, Director Common Stock, par value $0.001 per share 68.9K Jun 1, 2023 Direct
Kintara Therapeutics, Inc. President, CEO and Interim CFO, Director Options (Right to Buy) 23.1K Aug 30, 2023 Direct
Kura Oncology, Inc. Director Option to purchase common stock 23K Jun 22, 2021 Direct
FibroBiologics, Inc. Director Stock Option (Right to Buy) 5K Aug 27, 2024 Direct

Insider Reports Filed by Robert E. Hoffman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBLG FibroBiologics, Inc. Aug 27, 2024 1 $0 4 Aug 27, 2024 Director
FBLG FibroBiologics, Inc. Jan 24, 2024 0 $0 3/A Aug 13, 2024 Director
FBLG FibroBiologics Inc. Jan 24, 2024 0 $0 3 Feb 7, 2024 Director
KTRA Kintara Therapeutics, Inc. Aug 30, 2023 1 $0 4 Sep 1, 2023 President, CEO and Interim CFO, Director
KTRA Kintara Therapeutics, Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 President, CEO, and CFO, Director
KTRA Kintara Therapeutics, Inc. Aug 1, 2022 2 $0 4 Aug 3, 2022 President and CEO, Director
KTRA Kintara Therapeutics, Inc. Feb 15, 2022 1 $25.8K 4 Feb 17, 2022 President and CEO, Director
KTRA Kintara Therapeutics, Inc. Nov 8, 2021 1 $0 4 Nov 10, 2021 President and CEO, Director
KTRA Kintara Therapeutics, Inc. Sep 22, 2021 1 $0 4 Sep 22, 2021 Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director